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Abstract: HLA class II genes encode highly polymorphic heterodimeric proteins functioning to 
present antigens to T cells and stimulate a specific immune response. Many HLA genes are strongly 
associated with autoimmune diseases as they stimulate self-antigen specific CD4+ T cells driving 
pathogenic responses against host tissues or organs. High expression of HLA class II risk genes is 
associated with autoimmune diseases, influencing the strength of the CD4+ T-mediated 
autoimmune response. The expression of HLA class II genes is regulated at both transcriptional and 
post-transcriptional levels. Protein components of the RNP complex binding the 3′UTR and 
affecting mRNA processing have previously been identified. Following on from this, the regulation 
of HLA-DQ2.5 risk genes, the main susceptibility genetic factor for celiac disease (CD), was 
investigated. The DQ2.5 molecule, encoded by HLA-DQA1*05 and HLA-DQB1*02 alleles, presents 
the antigenic gluten peptides to CD4+ T lymphocytes, activating the autoimmune response. The 
zinc-finger protein Tristetraprolin (TTP) or ZFP36 was identified to be a component of the RNP 
complex and has been described as a factor modulating mRNA stability. The 3′UTR of CD-
associated HLA-DQA1*05 and HLA-DQB1*02 mRNAs do not contain canonical TTP binding 
consensus sequences, therefore an in silico approach focusing on mRNA secondary structure 
accessibility and stability was undertaken. Key structural differences specific to the CD-associated 
mRNAs were uncovered, allowing them to strongly interact with TTP through their 3′UTR, 
conferring a rapid turnover, in contrast to lower affinity binding to HLA non-CD associated mRNA. 
Keywords: celiac disease; Human Leukocyte Antigen (HLA), RNA binding protein; RNA stability; 
RNA structure 
 
1. Introduction 
HLA class II genes are the main risk factor associated with several autoimmune diseases 
(https://www.niehs.nih.gov/health/topics/conditions/autoimmune/index.cfm). These genes encode 
heterodimers presenting antigenic self-peptides that are expressed on the surface of antigen 
presenting cells (APC) such as dendritic cells, B lymphocytes, and macrophages, with the role of 
presenting antigens to CD4+ T cells. Following self-antigen presentation, cognate CD4+ T cells are 
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activated and proliferate determining the inflammatory response and organ damage. The expression 
of the HLA class II molecules influences the concentration of HLA-antigen complexes on APC and, 
consequently, the strength of CD4+ T cells autoimmune response. 
The expression of HLA class II genes is strictly regulated at the transcriptional level by a highly 
conserved regulatory module, situated 150–300 base pairs upstream of the transcription-initiation 
site [1]. This regulatory module interacts with several DNA binding factors, which, in turn, bind the 
HLA class II trans-activator CIITA [2]. The expression of HLA class II molecules has been 
demonstrated to be regulated through a mechanism that coordinates transcription and processing in 
the context of an “MHCII RNA operon”, a functional unit through which the UTRs of different MHC 
class II transcripts bind the same RNP complex [3,4]. Two RNA binding proteins, EBP1, ErbB3 
binding protein [5], and NF90 (Nuclear Factor 90) [6] were found to interact with stem-loop secondary 
structures at 5′ and 3′ UTRs of HLA-DRA and HLA-DRB1 mRNAs encoding for HLA-DR 
heterodimer, whose expression is downregulated by the depletion of both proteins. The discovery of 
a specific protein complex regulating the expression of HLA DR transcripts opens up the possibility 
that HLA-DQ, another isotype, may be regulated under the same mechanism. The HLA-DQ molecule 
is involved in self-antigen presentation, typical of many autoimmune pathologies. 
The HLA-DQ2.5 molecule is strongly associated with celiac disease (CD), a gluten-triggered 
disorder [7] and type 1 diabetes (T1D) [8], two autoimmune pathologies in which the main genetic 
predisposing factor is conferred by HLA-DQ2.5 encoding genes. More than 95% of CD patients 
express the HLA-DQ2.5 molecule, while the majority of remaining affected subjects carry the HLA-
DQ8 molecule. In T1D patients, the presence of the HLA-DQ2.5 molecule is less frequent than HLA-
DQ8, and 3.5–10% of individuals are affected by co-morbidities of CD and T1D. The surface 
expression of DQ2 and/or DQ8 molecules, on antigen presenting cells (APC), determines the level of 
self/gluten-antigen presentation and, consequently, the magnitude of the pathogenic autoimmune 
CD4+ T cell response leading to organ damage. It was recently demonstrated that DQA1*05 and 
DQB1*02 genes are more highly expressed than other non-CD-associated alleles in APC from CD 
patients carrying the DQ2-DR3 genotype in heterozygosis [9]. DQA1*05 and DQB1*02 mRNAs were 
found to show a similar stability, although lower with respect to other DQA1*01 and DQB1*05 non-
disease associated transcripts. In this study, the differential expression of HLA class II transcripts was 
investigated to ascribe a specific protein of the ribonucleoprotein complex to preferentially bind the 
autoimmune-associated transcripts.  
TTP (ZFP36) is a RNA binding protein that preferentially binds to AU-rich regions contained in 
the 3′UTR of target genes. TTP functions by destabilizing mRNAs encoding for oncogenes, cytokines 
(as TNFα), and chemokines involved in the inflammatory processes, by favoring their degradation 
and/or preventing their efficient translation [10,11]. Studies in TTP KO mice demonstrate that TTP 
not only regulates the primary immune cellular response to innate stimuli, but also regulates the 
expression of transcripts involved in the secondary response of fibroblasts/macrophages to the TNFα 
stimulation [12,13]. Here, the TTP protein is determined to be a component of the MHC operon and 
is involved in the regulation of the processing of the HLA-DQ genes. 
2. Results  
2.1. TTP Binds to CD—Associated and Non-Associated Transcripts 
To analyze the interaction of RNA binding proteins with 3′UTR of DQA1* and DQB1* 
transcripts, DNA templates were synthesized for in vitro transcription to obtain the different 
riboprobes. The cDNA of immortalized B-cells (B-LCL#5) obtained from a celiac patient carrying 
DQA1*01-DQA1*05/DQB1*02-DQB1*05 genotype [9] was used to synthetize the two riboprobes 
corresponding to 3′UTR of DQA1*05 (3DQA105 riboprobe) and DQB1*02 (3DQB102 riboprobe) 
mRNAs, encoding the DQ2.5 molecule associated with CD. The cDNA from HOM-2 cell line, 
carrying the homozygous DQA1*01/DQB1*05 genotype, was used for the synthesis of two riboprobes 
corresponding to the 3′UTR of DQA1*01 (3DQA101) and DQB1*05 (3DQB105) mRNAs, encoding 
DQ5 molecule not associated with disease. 
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REMSA experiments were performed. Figure 1A shows the interaction of 3DQA101 (Lanes 3 
and 6) and 3DQA105 (Lanes 9 and 12) riboprobes to S100 cytoplasmic extracts of M14 and B-LCL#5, 
respectively. It was also demonstrated that recombinant TTP (rTTP) interacts with either 3DQA101 
(Lanes 4 and 5) or 3DQA105 (Lanes 10 and 11) riboprobes.  
 
Figure 1. RNA binding proteins interaction. (A) REMSA experiments performed using 3DQA101 
(Lane 1) and 3DQA105 (Lane 9) riboprobes. Lanes 2 and 8 show the digestion of riboprobes with T1 
RNase. The binding of DQA101 with M14 extract is in Lane 3 and with B-LCL#5 extract in Lane 6. The 
binding of 3DQA105 with M14 extract is in Lane 9 and with B-LCL#5 extract in Lane 12. The 
interaction of 5 and 1 µg of rTTP with 3DQA101 is shown in Lanes 4 and 5 and with 3DQA105 in 
Lanes 10 and 11. (B) Western blot analysis of biotin pull-down assay carried by using 3DQA101, 
3DQA105, 3DQB102, and 3DQB105 riboprobes. The antibodies used for the immunoblot were anti-
NF90, anti-TTP, and anti-EBP1. Molecular weights are as indicated. 
To confirm that this complex includes the same proteins previously identified, a pull-down 
assay was performed (Figure 1B). In vitro transcribed biotinylated riboprobes, 3DQA101, 3DQA105, 
3DQB102, and 3DQB105, were incubated with S100 cytoplasmic extract of B-LCL#5 and, after pull-
down with streptavidin coated beads, proteins interacting with biotinylated riboprobes were 
detected by Western blot analysis. By using anti-NF90, anti-EBP1 and anti-TTP, it was demonstrated 
that all three proteins bind to the 3′UTRs of DQA1* and DQB1* mRNAs. In conclusion, NF90 and 
EBP1, previously identified as components of the complex interacting with 3′UTRs of DRA and DRB1 
mRNA [3,4], were confirmed to interact with DQ riboprobes while, for the first time, TPP was 
identified to be a component of the RNP complex binding the HLA-DQA1*01, DQA1*05, DQB1*02, 
and DQB1*05 mRNAs. 
2.2. Analysis of DQA1* and DQB1* 3′UTR Sequences 
TTP interacts with transcripts via the specific AU-rich AREs in the 3′UTR of target genes and is 
influenced by the folding of the mRNA itself. Therefore, it was investigated whether differences in 
the nucleotide sequences may affect RNA folding, the distribution of AU rich elements, and their 
secondary structure accessibility along the 3′UTR. Firstly, by comparing the nucleotide sequences of 
the 3′UTRs of DQA1*05 and DQB1*02, CD-associated transcripts, with the 3′UTRs of DQA1* 01 and 
DQB1*05, non-CD-associated transcripts and to highlight the differences in Figure 2A,B. In the 
DQA1* alleles, a 94.1% identity was observed and a small difference in the overall GC content with 
the DQA1*01 allele at 0.46 as compared to DQA1*05 at 0.44 (Figure 2A). In the DQB1* alleles, the 
53kDa
48kDa
3D
QA
10
1
3D
QA
10
5
3D
QB
10
2
3D
QB
10
5
Ctr
l -
EBP1
90kDaNF90
TTP
B
Labeled RNAs3DQA101
1         2        3        4       5       6     7        8        9      10       11       12       
3DQA105
A
Cells 2019, 8, 1570 4 of 13 
 
sequence identity between 3DQB102 and 3DQB105 riboprobes was lower, at 92.3%, despite the alleles 
sequence having identical GC content (0.55) (Figure 2B). The sequence differences between alleles are 
likely to influence the secondary structures of the RNAs, minimum-free energy (MFE) structure 
predictions were performed (Figure 2C,D), and mapped on the canonical ARE (AUUUA/AUUUUA) 
and half-ARE (UAUU) motifs associated with TPP binding [11,14]. A longer length ARE sequence 
has been defined as WWAUUUAWW [13](W represents A or U), however this motif is not present 
in the DQA1* or DQB1* 3′UTRs. The canonical ARE and half-ARE motifs are present in both 
3DQA101 and 3DQA105 riboprobes. In contrast, the ARE motif is only found in the 3DQB102 
riboprobe (Figure 2D), suggesting the potentiality for TTP to bind to CD-associated transcripts. 
Alignments of the DQA1* and DQB1* alleles with their mouse homologs, H2-Aa and H2-Ab1 (Figure 
S1), reveal sequence identities of DQA1* and DQB1* with their mouse homologs to be <60% and 
<40%, respectively, indicating a low level of conservation of the UTRs across species. 
 
Figure 2. Sequences and structures comparison between 3′UTR of DQA1* and DQB1* genes. (A) 
Comparison of the 3′UTR sequences for the DQA1*01 and DQA1*05 alleles indicates 94.1% sequence 
identity. There is a slightly higher proportion of GC content in the DQA1*01 allele (0.46) as compared 
to DQA1*05 (0.44). (B) The DQB1*05 and DQB1*02 alleles show a lower sequence identity (92.3%), but 
identical GC proportions (0.55). (C, D) RNA secondary structure prediction reveals the sequence 
differences between alleles impacts the minimum-free energy folding (RNAfold). Common structural 
motifs from FOLDALIGN are mapped onto the structures as well as canonical ARE 
(AUUUA/AUUUUA) and half-ARE motifs (e.g., UAUU). 
To assess RNA secondary structure stability between the DQA1* and DQB1* pairs, ensembles of 
statistically sampled structures using Sfold [15] were calculated (Figure S1). The ensembles represent 
the full range of structures a sequence can adopt, not just those with the lowest MFE, highlighting 
substructures that remain constant across all structure conformations. MFE prediction makes the 
assumptions that there is a single rigid structure and that the energy parameters are complete. 
However, it is likely that mRNAs are more dynamic and can adopt multiple conformations 
depending on their environment and presence of RNA binding proteins. Across the predicted 
ensemble structures the conserved substructures co-localize with the ARE and half-ARE sequence 
motif positions in the 3DQA101, 3DQA105, and 3DQB105 mRNAs. The 3DQB102 ARE is outside of 
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a predicted stable substructure, indicating it is likely to be more flexible and adopt a range of 
structural conformations. The proportion of the 3DQB102 structure with predicted conserved 
substructures between ensembles and minimum-free energy predictions, and those from 
FOLDALIGN (see below), is lower than in the other alleles and, importantly, does not contain AU–
rich elements, indicating that TTP may bind in regions with low structural stability.  
Structural motif searches between pairs of 3′UTRs with FOLDALIGN [16] determine if there are 
any common structural motifs (defined by sequence and secondary structure) that could confer an 
RNA Operon-like module as previously found [4]. The presence of a common motif present in 
different structures could indicate a common RNA-binding protein site. The identified common 
structural motifs have been mapped onto the structures in Figure 2C,D. Structures common to the 
DQA1* and DQB1* pairs were found and support the hypothesis this could enable them to co-bind 
in an “RNA Operon”, as has been previously demonstrated for the HLA-DR alleles [4]. 
A more extensive AU rich motif search was undertaken to determine if there are further, possibly 
weaker, TPP binding sites in the riboprobes and whether there are differences between the CD and 
non-CD associated allele pairs. A kmer analysis at a range of motif lengths (di, tri, tetra, penta, and 
hexa nucleotides) shows a clear pattern of enrichment of AU containing motifs in the CD associated 
alleles as compared to the non-disease associated across all kmer lengths (Figure 3A). Mapping the 
AU rich kmers onto the riboprobe sequences reveals the CD associated alleles contain more AU rich 
sites located across the full length of the sequence and therefore are likely to confer more TPP binding 
through these AU motifs. Individual AU rich kmers are also more commonly seen in clusters together 
in close proximity in the CD associated alleles than those non-disease associated (Figure 3B). 
 
Figure 3. AU-rich motif analysis of the DQA1* and DBQ1* genes reveals key differences. (A) All 
possible di-, tri-, tetra-, penta- and hexa-mers are assessed for their observed frequencies against their 
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expected frequencies. AU-rich motifs are colored, non-AU rich in grey. All AU-rich kmer motifs have 
higher enrichments in the CD associated DQA1*05 and DQB1*02 alleles as compared to the non-CD 
associated DQA1*01 and DQB1*05 alleles. (B) Mapping the AU-rich motifs to their position within 
the 3′UTR sequences reveals a clear enrichment in AU-motifs throughout the CD associated alleles 
DQA1*05 and DQB1*02 (Blue) as compared to the non-CD associated DQA1*01 and DQB1*05 alleles 
(Red). Nested motifs are indicated on the y-axis; for example, two overlapping motifs will show a 
score of 2. A structure accessibility score indicates the likelihood the RNA single stranded, an absence 
of base-pairing, across its length. A score of 1.0 indicates the structure is single stranded. 
The secondary structure context of the AU rich kmers is likely to influence the ability of TPP to 
bind in a sequence specific manner. Therefore, RNAplfold was used to calculate a secondary structure 
accessibility score, indicating the probability of whether the RNA is likely to be single stranded along 
its length. In the DQA1* alleles, the AU motifs are more prevalent in the CD-associated allele; 
however, they tend to be localized in regions with a lower probability of being single-stranded than 
the non-disease associated allele. In DQB1*, the AU motifs in the CD-associated alleles are not only 
more common but also colocalized with single-stranded regions, in contrast the AU motifs in the 
non-disease allele are not in single-stranded regions. 
In conclusion, the in silico analysis predicts that TTP binds to HLA-DQA1 and HLA-DQB1 
mRNAs and that the secondary structures adopted by the alleles facilitate the interaction of TTP with 
the 3′UTR of CD-associated mRNAs. According to the canonical role of TTP, this binding should 
confer lower stability to transcripts respect to non-CD associated mRNAs. 
2.3. Knockdown of TTP Affects the Expression Level of DQA1 and DQB1 Transcripts 
It was previously demonstrated that there is differential expression of CD-associated transcripts, 
DQA1*05 and DQB1*02, and lower half-lives in respect to non-CD associated DQ transcripts in B-
LCL#5 cells [9]. To investigate if the TTP protein is responsible for the DQ mRNAs turnover, the 
protein was depleted by specific siRNAs transfection in M14 and B-LCL#5 cell lines. The knockdown 
of TTP was first assayed in M14, 48 h after transfection by Western blot with anti-TTP (Figure 4A), in 
which we observed 80% depletion. When we measured the mRNA by qRT-PCR, we found 2–3-fold 
increase of DRA, DRB1*, and DQA1* transcripts (Figure 4B). As a control of the knockdown 
specificity, no variations were found in the expression of two groups of genes related to this system, 
the HLA-A, -B, and -C class I genes and CIITA, the HLA class II transcriptional activator. In parallel, 
a TTP knock-down was performed in B-LCL#5 cells by specific siRNA nucleofection, and the protein 
depletion after 48 h by Western blot was confirmed (Figure 5A).  
 
Figure 4. TTP knockdown in M14. (A) Western blot performed with anti-TTP for the assessment of 
protein depletion 48 h after silencing with siCtlr or siTTP (B) Fold variation of DRA, DRB1, and DQA1 
mRNAs. HLA-a,b,c are the class I mRNAs, CIITA is the HLA class II transcriptional transactivator. 
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The TTP knockdown affects the phenotype of the cells and, by flow cytometry analysis, higher 
HLA-DQ surface expression was observed (Figure 5B). To evaluate whether the DQ increase 
corresponds to the HLA-DQ mRNAs variation qRT-PCR was carried out, revealing a 2.7- and 2.9-
fold increase of DRA and DRB1* mRNAs, respectively. Total DQA1* and DQB1* mRNAs showed a 
three-fold increase compared to the control (siCtlr) and in respect to the HLA class I mRNAs (Figure 
5C). To investigate if TTP affects the expression of each mRNAs, DQA1*01, DQA1*05, DQB1*02, and 
DQB1*05 mRNAs were specifically quantified. This confirmed that DQA1*05 and DQB1*02 have a 
higher expression than DQA1*01 and DQB1*05 (Figure 5C) as previously demonstrated [9]. 
However, when comparing the amount of different messengers after TTP knockdown, it was 
observed that DQA1*05 and DQB1*02 mRNAs showed a greater and significant increment (3.5-fold 
increase), in respect to DQA1*01 and DQB1*05 mRNA (two-fold increase, Figure 5D). 
In conclusion, the depletion of TTP protein, as well as interaction with 3′UTR, determines an 
increment of the CD-associated DQA1*05 and DQB1*02 mRNAs greater than that of the non-CD-
associated DQA1*01 and DQB1*05 mRNAs. 
 
Figure 5. TTP knockdown in B-LCL#5. (A). Western blot performed with anti-TTP for the assessment 
of protein depletion 48 h after silencing with siCtlr or siTTP nucleofection. (B) Cytofluorimetric 
analysis of HLA-DQ surface expression, reported as fold change of MFI (Mean Fluorescence 
Intensity). (C) Fold variation of DRA, DRB1, DQA1, DQB1, and HLA-A, -B, and -C (class I) mRNAs. 
(D) Fold variation of DQA1*01, DQA1*05, DQB1*02, and DQB1*05 mRNAs. 
3. Discussion  
In many autoimmune diseases, HLA class II molecules are expressed on APCs and present self-
antigens to CD4+ T cells. The magnitude of the CD4+ T cell activation and proliferation is related not 
only to the nature of cognate epitopes, but also to the amount of the antigen-HLA class II complexes 
expressed on the surface of APCs [17]. In this respect, the expression level of HLA class II molecules 
that restricts the antigenic responses is very important, particularly in autoimmune diseases as the 
HLA class II encoding genes represent the main genetic risk factor associated with these pathologies. 
Previously, it was demonstrated that there are similar amounts of DQ2.5 molecules in APCs of 
CD patients of either heterozygous or homozygous for DQ2.5 risk genes [9]. Consequently, DQ2.5 
heterozygous or homozygous APCs induced a similar strength of functional immune response by 
gluten-reactive CD4+ T cells. The equivalent surface density of DQ2.5 heterodimer on cells from 
homozygous and heterozygous CD patients has been linked to the marked difference in expression 
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of DQA1*05 and DQB1*02 risk genes, in respect to the reduced expression of non-disease associated 
DQA1*01 and DQB1*05 alleles, in the DQ2.5 heterozygous genotype. This difference in the quantity 
of transcripts might be explained by haplotype-specific transcriptional regulation or allele-specific 
mRNA processing [17]. Indeed, the transcripts of both CD-associated DQA1*05 and DQB1*02 genes 
showed a similar decay kinetic (3 h half-life), but much lower in respect to non-CD-associated 
DQA1*01, DQB1*03, and DQB1*05 mRNAs (4 h half-life) [9]. This difference in the transcript turnover 
led to the hypothesis that a protein complex might differentially bind the autoimmune-associated 
messengers, and therefore modulate their decay. 
The analysis of 3′UTR of CD-associated DQA1*05 and DQB1*02, and non-CD associated 
DQA1*01 and DQB1*05 alleles revealed several differences in GC content and in canonical ARE 
(AUUUA) and half-ARE (UAUU) motifs in addition to base differences that influence the secondary 
structures and binding sites of the RNAs. The predicted RNA structures show no differences in the 
motifs containing common substructures between DQA1* mRNAs, but lower structural stability for 
DQB1*02. The lower stability of this transcript influences the half-life of DQA1*05, as the turnover of 
the two mRNAs is co-regulated. In other words, the amount of a messenger establishes the quantity 
of its partner messenger coupled in the same RNP complex [4,17]. REMSA experiments confirm the 
in silico findings, revealing the interaction of cytoplasmic extracts with 3′UTR of DQA1*01 and 
DQA1*05 transcripts. Importantly, this indicates that the RNA binding proteins included in the 
complex are constitutively expressed by either professional (B-LCL) and/or non-professional antigen 
presenting cells (M14). Moreover, in these experimental conditions, the 3′UTR of DQB1*02 and 
DQB1*05 RNAs do not show binding with cytoplasmic extracts. The absence of binding with beta 
riboprobes may be caused by the radiolabeling of the 3′UTRs affecting their secondary structures, 
therefore the RNA–protein interaction was investigated by an end-labeled desthiobiotin based pull-
down method that does not interfere with the RNA structure. Indeed, following the efficient 
enrichment of the protein–RNA complexes, assessed by immunoblot, the interaction of two RNA 
binding proteins, EBP1 and NF90, previously identified in the complex with of DRA and DRB1* 
3′UTR [3,4], with four 3DQA105, 3DQA101, 3DQB102 and 3DQB105 riboprobes analyzed in this work 
was confirmed. 
To investigate the different turnover of messengers, the interaction of TTP (ZNFP36), a zinc 
finger protein interacting with AU-rich elements (ARE)-containing mRNAs promoting rapid 
cytoplasmic decay through acceleration of deadenylation rate was investigated [18]. The interaction 
of recombinant TTP to the 3′UTR of all transcripts was assayed by REMSA and/or pull-down. In 
addition, to verify if TTP protein affects the stability, the depletion by specific siRNA was undertaken, 
and, as expected, an increase of HLA class II mRNAs was observed, in both cell lines, while HLA 
class I and CIITA mRNAs were unaffected. Notably, in B-LCL#5, TTP depletion results in a 3.5-fold 
increase of DQA1*05 and DQB1*02 mRNAs and two-fold increase of DQA1*01 and DQB1*05 
mRNAs. These results clearly indicate a stronger binding of TTP and a consequent lower stability of 
CD-associated messengers in respect to non-CD associated alleles.  
Tristetraprolin has previously been shown to bind via canonical ARE (AUUUA) motifs, present 
in the upstream region of 3DQA101 and 3DQA105 riboprobes. In addition to the ARE motifs, there 
are also half-ARE (UAUU) motifs present in the 3DQA101 (two copies) and 3DQA105 riboprobes 
(Figure 1). More recently, TTP was found to bind to AU-rich sequences [11,14], and through sequence 
analysis an enrichment of AU-rich motifs with TPP binding potential in the CD-associated alleles as 
compared to the non-CD associated was demonstrated. These motifs are located throughout the 
sequences of the CD-associated alleles in contrast the non-CD-associated alleles where they form a 
cluster within positions 90–160 (approximate) (Figure 2). The sequence and AU-rich motif 
distribution differences between the DQA1 and DQB1 alleles is also likely to have an impact on the 
secondary structures of the RNAs and their accessibility to TPP binding. The analysis of the 
ensembles of predicted structures indicates that, in addition to the sequence motifs, there are 
differences in the structure stabilities contributing to the observed differences of TPP binding 
affinities (Figure S1). Across all the secondary structure conformations (ensembles) that can be 
adopted by each of the RNA alleles, it was observed that ARE motifs are co-located with the 
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substructures present across all ensemble structures, thus indicating that they are present in the more 
stable sections of the structures. In the case of 3DQB102, an ARE is not found in the 3DQB105 
riboprobe, indicating that TPP binding may higher affinity in 3DQB102, although this ARE is outside 
of the more stable substructures. In conclusion, the in silico analysis demonstrates that CD-associated 
mRNAs can strongly interact with TTP through their 3′UTR, conferring a more rapid mRNA 
turnover. 
mRNAs controlling inflammation in mice were recently investigated, where it has been reported 
that no significant binding of TTP has been detected to H2-Aa and H2Ab1 mRNA, the mouse HLA-
DQ-homologous transcripts [13]. However, there is low sequence identity between human and 
mouse HLA-DQ 3′UTRs (see Figure S2). Therefore, the function of TTP as an RNA-binding protein 
is likely to be more context-dependent than previously described in the literature and the canonical 
binding site is present in stable as well as unstable TTP-bound mRNAs. 
In addition, there is a stronger impact of TTP-dependent mRNA degradation on the 
transcriptome of macrophages activated by lipopolysaccharide (LPS) during the early resolution 
phase of inflammation than during the onset of inflammation [13]. Inflammation is linked to the 
adaptive immune response since, following HLA-antigen complexes recognition, proliferating CD4+ 
T cells activate macrophages through cell-to-cell contact and IFN-γ secretion. TTP-mediated 
regulation of the HLA-DQ2 mRNAs stability is therefore proposed to occur during the resolution 
phase of inflammatory response. TTP interaction with these transcripts may counterbalance the high 
transcriptional expression of DQ2 genes and modulate the CD- and T1D-related antigen presentation.  
4. Conclusions 
In previous work, it has been demonstrated that, in addition to HLA class II predisposing 
genotype, the high expression of risk alleles is relevant in the establishment of autoimmunity. In fact, 
the magnitude of the T cell activation and proliferation is related not only to the nature of the antigen 
but also to the amount of the antigen-HLA class II complexes expressed on the surface of APCs. The 
gene expression is mainly regulated at the transcriptional level, but RNA processing may also have 
an important role in the differential transcript synthesis. TTP/ZNFP36 RNA binding protein was 
identified as a member of RNP complex regulating the stability of HLA class II mRNA associated to 
CD and T1D. Most importantly, with the support of in silico approaches, it was revealed that the CD-
associated mRNAs can strongly interact with TTP through their 3′UTR, conferring a more rapid 
mRNA turnover. These findings demonstrate that the synergy among molecular and in silico analysis 
unravel an allele-specific regulation.  
5. Materials and Methods 
5.1. Cell Lines  
M14 human melanoma and human HOM cell lines (DQA1*01/DQB1*05 genotype) were 
obtained by ECACC (Sigma-Aldrich, Milan, Italy). B-LCL#5 are EBV-transformed B lymphoblastoid 
cell lines immortalized from PBMCs of celiac patients carrying DQA1*01-DQA1*05/DQB1*02-
DQB1*05 genotype [9]. All cell lines were cultured in RPMI 1640 medium (Euroclone, Milan 
Italy)supplemented with 10% Fetal Calf Serum (Euroclone, Milan, Italy)).  
5.2. DNA Templates Synthesis and mRNA Quantification 
The sequences of specific HLA alleles were obtained from the HLA database 
(http://www.ebi.ac.uk/ipd/imgt/hla/index.html) and the primers used for PCR and qRT-PCR were 
picked analyzing the sequences by Prime3web (http://primer3.ut.ee/) and then synthesized by 
Eurofins Genomics (Ebersberg, Germany). Some of the primers have been already used [9], and all 
sequences of are listed in Table 1. The template for 3DQA105 riboprobe synthesis was previously 
prepared [3], while the others obtained from retro-transcribed RNA. Specifically, we used cDNA 
from B-LCL#1 to obtain 3DB102 template and cDNA from HOM cell to synthetize 3DQA101 and 
DQB105 templates. Total RNA was prepared with the AurumTM Total RNA kit (BIORAD, Milan, 
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Italy), and 1 µg of RNA was used for reverse transcriptase reactions, performed using an iScriptTM 
cDNA Synthesis kit (BIORAD). To quantify specific transcripts, we performed qRT-PCR using the 
Quanti Tect SYBR Green PCR Kit (BIORAD) through the DNA Engine Opticon Real-Time PCR 
Detection System (BIORAD). Each reaction was run in triplicate in the presence of 0.2 mM primers. 
The relative amount of specific transcripts was calculated by the comparative cycle threshold method 
[19], and GAPDH and β-actin transcripts were used for normalization. All results shown are the mean 
of at least three independent experiments. Statistical analysis was performed using the unpaired 
Student’s t-test with two-tailed distribution and assuming two samples equal variance parameters. 
In the figures, a single asterisk corresponds to p < 0.05 and double asterisks correspond to p < 0.01. 
Table 1. List of primers  
Primers Used for qRT-PCR 
Gene Primers Sequences 5′ → 3′ 
β-Actin ACT-F  ACT-R 
TCATGAAGTGTGACGTTGACA 
CCTAGAAGCATTTGCGGTGCAC  
GAPDH G-F 
G-R 
AACGGATTTGGTCGTATTGGGC 
TCGCTCCTGGAAGATGGTGATG 
HLA-DRA DRA-F  DRA-R 
GGACAAAGCCAACCTGGAAA  
AGGACGTTGGGCTCTCTCAG 
HLA-DRB1 
DRB1-F  
DRB1-R 
CTCAGCATCTTGCTCTTGTGCAG 
CAGCATTAAAGTCAGGTGGTTCC 
HLA-DQA1  DQA1-F  
DQA1*R 
GGTGTAAACTTGTACCAGT 
GGAGACTTGGAAAACACT 
HLA-DQB1 DQB1-F  
DQB1*R 
CAGATCAAAGTCCGGTGGTTT 
TCTGGGCAGATTCAGACTGAGC 
HLA-A, -B, and -C 
MHCI-F 
MHCI-R 
AGTGGGCTACGTGGACGACA 
ATGTAATCCTTGCCGTCGTA 
HLA-DQA1*05 
alfa05-F  
alfa05-R 
CGGTGGCCTGAGTTCAGCAA 
GGAGACTTGGAAAACACTGTGACC 
HLA- DQA1*01 alfa01-F  
alfa01-R 
CGGTGGCCTGAGTTCAGCAA 
GGAGACTTGGAAAACACTGTGACC 
HLA- DQB1*02 
beta02-F  
beta02-R 
TCTTGTGAGCAGAAGCATCT 
CAGGATCTGGAAGGTCCAGT 
HLA- DQB1*05 
beta05-F  
beta05-R 
ACAACTACGAGGTGGCGTACC 
CAGGATCTGGAAGGTCCAGT 
Primers used for PCR of riboprobes templates 
Probe Primers Sequences 5′ → 3′ 
3DQA101 3DQA101T7 
3DQA101R 
TAATACGACTCACTATAGGCCATCCTGG
AAGGGAAGTG 
TCAGGAGGTCAGGGAAAGAA 
3DQA105 3DQA105T7 3DQA105R 
TAATACGACTCACTATAGGATCCCATCCT
GGAATGGAAGTG 
AAAGGCATTTGTGAGCTCTGAGCAG 
3DQB102 
3DQB102T7 
3DQB102R 
TAATACGACTCACTATAGGGGCACTGAC
TCCTGAGACT 
GCTGTGGGTCAGTGCAG 
3DQB105 3DQB105T7 
3DQB105R 
TAATACGACTCACTATAGGGGCACTGAC
TCCTGAGACTGT 
GGCTGTGGGTCAGTGCAG 
  
Cells 2019, 8, 1570 11 of 13 
 
5.3. RNA Electrophoretic Mobility Shift Assay (REMSA) and Pull-Down  
The riboprobes synthesis and REMSA were performed according to the published protocol [3,4]. 
Briefly, the transcription reactions were performed using T7 in vitro transcription system (Ambion, 
Thermo Fisher, Milan, Italy) in presence of [32P] UTP (PerkinElmer, Milan, Italy) and riboprobes 
obtained were used in binding experiments with M14 and B-LCL#5 S100 extract. TTP recombinant 
proteins was produced as described [20]. 
For pull-down experiments, riboprobes were end-labeled with desthiobiotin cytidine and used 
in binding experiments with 60 µg of B-LCL#5 cytoplasmic extract with the Thermo Scientific Pierce 
Magnetic RNA-protein pull down kit (Thermo Fisher, Milan, Italy). The riboprobe used as negative 
controls was the 3′UTR of androgen receptor RNA poly(A)25 RNA, provided by the kit. 
Desthiobiotinylated target RNAs bound to proteins were captured using streptavidin magnetic 
beads and, following washing and elution, the proteins interacting with RNA were separated by SDS-
PAGE and analyzed by Western blot (Euroclone, Milan, Italy). We used three different antibodies, 
namely anti-DRBP76 (anti-double stranded RNA binding protein 76 or anti-NF90) antibody (BD 
Biosciences, Milan, Italy), N-terminus anti-EBP1 (Abcam, Cambridge, UK), and anti-TTP 
(Tristetraprolin, Santa Cruz Biotechnology, Dallas, TX, USA), to reveal the presence of proteins in the 
RNP complex binding 3′UTR.  
5.4. TTP Silencing and Phenotype Analysis 
The plasmid for recombinant wild-type (AA) His-tagged TTP proteins (kindly provided by Dr. 
Tiedje) have been used to transfect HEK293 cells and protein purification using nickel-chelate agarose 
beads and following a protocol already described [20]. After imidazole elution, samples were 
dialyzed and stored at −80 °C in a solution made of 20 mM HEPES pH 8, 100 mM NaCl, 3 mM MgCl2, 
and 8% glycerol.  
For TTP depletion, we performed gene silencing using a pool of four different siRNA provided 
by Santa Cruz Biotechnology. In total, 5 × 105 B-LCL#5 cells, transfected by nucleofector technology 
and Lonza kit, were harvested after 48 h either for protein extraction, flow cytometry analysis and 
RNA preparation. TTP depletion and overexpression were assessed by Western blot using an anti-
TTP antibody. The HLA-DQ cell surface expression was performed by cytofluorimetric analysis 
using the FACSAria III and DIVA software with FITC mouse anti-human HLA-DQ antibody (BD 
Biosciences). The quantitation of specific transcripts was performed by qRT-PCR as described in [9], 
using primers listed in Table 1.  
6. Bioinformatics Analysis 
Sequence alignments and identities were calculated using the global Needleman–Wunch 
algorithm [21], via EMBL-EBI API (https://www.ebi.ac.uk/Tools/psa/emboss_needle). Minimum Free 
Energy (MFE) RNA secondary structures were predicted using RNAfold [22] from single sequences. 
Structure accessibility probability scores were calculated using RNAplfold, [22] using a temperature 
of 37 °C, window size of 75 and mean structure score for fragments of 10 nt (RNAplfold -T 37 -W 75 
-u 10) [13]. These parameters are similar to those used in the TPP Atlas describing transcriptome-
wide TPP binding. In addition to MFE structure calculations, an ensemble of statistically sampled 
structures was generated using Sfold [15], for each riboprobe sequence indicating the most structured 
parts of the molecules common to the predicted ensemble clusters. To identify common structural 
motifs between the DQA1 and DQB1 sequences, we ran Foldalign [23], in a pairwise all-against-all 
search. Bracket notation secondary structure from RNAfold were rendered into images with selected 
motifs mapped onto them using FORNA [24]. 
AU rich motif mapping and enrichment analysis was performed with custom scripts, freely 
available at https://github.com/darogan/Tristetraprolin_Pisapia_DelPozzo including R code to 
recreate Figure 2. All possible kmers, for lengths 2, 3, 4, 5 and 6, were created for each of the riboprobe 
sequences, and the observed versus expected ratios calculated. Subsets of AU rich motifs are 
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highlighted in the plots. We then mapped the same AU motifs onto each of the riboprobe sequences. 
Nested structures, i.e., overlapping, are indicated by the score on the y-axis of Figure 2. 
Supplementary Materials: The following are available online at www.mdpi.com/xxx/s1, Figure S1: Sfold 
Structure Comparison of 3′UTR of DQA1* and DQB1*. Each of the riboprobe sequences was analyzed with Sfold 
to predict statistical ensembles of structures. The ensembles permit many different conformations of the 
structures and clustering, indicating the most likely conformations adopted by each sequence. The minimum-
free energy (MFE) structure is also predicted and its parent cluster identified. (A) 3DQA101; (B) 3DQA105; (C) 
3DQB105; and (D) 3DQB102 show the ensemble structures to contain fewer conserved base pairings (grey boxes) 
than the MFE structure indicating the structure is more dynamic/flexible outside of these regions. This is 
particularly evident in (D) (3DQB102) where there is little conservation of base pairings in the large stem, as seen 
in the other structures, Figure S2: Sequence Alignment for human and mouse homologs for DQA1* and DQB1* 
alleles. The sequence alignments for the human DQA1* and DQB1* 3′UTR sequences in Figure 1A,B have been 
extended to include the mouse homologs H2-Aa and H2-Ab1. (A) The DQA1* alignment for the human alleles 
and mouse homolog show high sequence identity between the human alleles at 94.1% but a much lower identity 
between the human and mouse sequences (<60%) as summarized in (B). (C) The DQB1* alignment for the human 
alleles and mouse homolog show a low sequence identity of <45% between species but >90% for the human 
sequences as summarized in (D). The low level of conservation between human and mouse (<60% for DQA and 
<45% for DQB) will result in different locations of AU rich motifs and affect their presentation in single stranded 
RNA structure regions. 
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